Stentys Completes APPOSITION II Enrollment

July 15, 2010—Stentys, Inc. (Princeton, NJ) announced the completion of patient enrollment in the APPOSITION II clinical study, a randomized trial comparing the Stentys self-expanding stent with a conventional balloon-expandable stent in patients with acute myocardial infarction (AMI). The study results will be announced in September.

According to the company, the self-expanding Stentys stent's shape and diameter adapt to the anatomic changes of the coronary arteries during the post-AMI phase. By being in permanent contact with the vessel wall, the device avoids malapposition.

“The Stentys stent, once implanted, continues expanding and, in our experience, has provided very good apposition to the wall of the vessel compared to conventional stents,” commented study investigator Corrado Tamburino, MD. “This is important because malapposition is one of the factors causing stent thrombosis.”